Company Arch Therapeutics, Inc.
Equities
ARTH
US03939W2089
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | 0.00% | +9.47% | -85.64% |
Business Summary
Number of employees: 8
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biotechnology
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +383.80% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +383.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 15/09/09 |
Michael Abrams
DFI | Director of Finance/CFO | 55 | 09/05/21 |
Shawn Carlson
SAM | Sales & Marketing | - | 31/12/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 15/09/09 |
Fish Guy
BRD | Director/Board Member | 64 | 30/12/21 |
Laurence Hicks
BRD | Director/Board Member | - | 26/09/21 |
Punit Dhillon
BRD | Director/Board Member | 44 | 30/06/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,444,363 | 3,252,501 ( 73.18 %) | 0 | 73.18 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-85.64% | 4.62M | |
+8.29% | 124B | |
-5.61% | 11.02B | |
+4.83% | 8.88B | |
+39.60% | 5.45B | |
-22.04% | 4.74B | |
+8.39% | 3.44B | |
-6.28% | 2.84B | |
-10.23% | 2.15B | |
-5.99% | 2.11B |
- Stock Market
- Equities
- ARTH Stock
- Company Arch Therapeutics, Inc.